Company profile for Ventoux Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ventoux Biosciences develops locally delivered therapies targeting fibrosis. Lead candidate VEN‑201 is positioned for first-line treatment and recurrence prevention in Dupuytren’s disease. A platform approach extends into central nervous system fibrosis, where localized activity supports modulation of scarring and potential neural regeneration. Founded by a patient with biopharma experience, the organization integrates liv...
Ventoux Biosciences develops locally delivered therapies targeting fibrosis. Lead candidate VEN‑201 is positioned for first-line treatment and recurrence prevention in Dupuytren’s disease. A platform approach extends into central nervous system fibrosis, where localized activity supports modulation of scarring and potential neural regeneration. Founded by a patient with biopharma experience, the organization integrates lived insight with scientific rigor across underserved fibrotic conditions.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
315 S. Coast Highway 101 Suite U245 Encinitas, CA 92024
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

IPhEB Russia

Not Confirmed

envelop Contact Supplier

IPhEB Russia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty